Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks safety of efgartigimod during pregnancy and breastfeeding

NCT ID NCT06299748

Recruiting now Knowledge-focused Sponsor: argenx Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows pregnant women who have taken efgartigimod for myasthenia gravis or CIDP, as well as women exposed only during breastfeeding. Researchers will monitor pregnancy outcomes and infant health, including birth defects, to better understand the drug's safety. The goal is to gather real-world data to guide treatment decisions for these conditions during pregnancy and breastfeeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Efgartigimod
What this could lead to
If successful, this study could provide crucial safety data to help doctors and patients make informed decisions about using efgartigimod during pregnancy or breastfeeding.
What could go wrong
This is an observational safety study, not a treatment trial. It does not test whether efgartigimod works, and results may take years to gather. The study is relatively small and may not detect rare risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic inflammatory demyelinating polyradiculoneuropathy myasthenia gravis polyneuropathy, inflammatory demyelinating, chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MYASTHENIA GRAVIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, 00168, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitari Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Klinikum der Ruhr-Universität Bochum St. Josef Hospital Neurologische Interdisziplinäre Infusionsambulanz + MS Studienambulanz (Haus E Ebene1)

    RECRUITING

    Bochum, 44791, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • United BioSource LLC

    RECRUITING

    Morgantown, West Virginia, 26508, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.